Histopathologic parameters of prognosis in cervical cancer - A review

International Journal of Gynecological Cancer

Volumn 14, Issue 5, 2004, Pages 741-750

  Singh, Naveena ^a   Arif, S ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Cervical cancer; Depth; Grade tumor type; Grading systems; Histopathology; Margins; Prognosis; Stage; Vascular invasion; Volume

Indexed keywords

ADVANCED CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; IN VIVO STUDY; LYMPH NODE; LYMPH NODE METASTASIS; MEASUREMENT; OUTCOMES RESEARCH; PARAMETER; PELVIS LYMPH NODE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; REVIEW; SCORING SYSTEM; STANDARD; SURVIVAL TIME; TUMOR VOLUME; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; REPRODUCIBILITY OF RESULTS; UTERINE CERVICAL NEOPLASMS;

EID: 4544281012     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1048-891X.2004.014504.x     Document Type: Review

References (95)

1. Smiley LM, Burke TW, Suva EG, Morris M, Gershenson DM, Wharton JT. Prognostic factors in stage IB squamous cervical cancer patients with low risk for recurrence. Obstet Gynecol 1991;77:271-5.
2. Pecorelli S, Benedet JL, Creasman WT, Shepherd JH. FIGO staging of gynecologic cancer 1994-1997 FIGO committee on gynecologic oncology. International federation of gynecology and obstetrics. Int J Gynaecol Obstet 1999;64:5-10.
3. Burghardt E, Ostor A, Fox H. The new FIGO definition of cervical cancer stage IA: a critique. Gynecol Oncol 1997;65:1-5.
4. The Royal College of Pathologists. Minimum dataset for the reporting of cervical neoplasia. Standards and minimum datasets for reporting cancers. 2001.
5. Creasman WT, Fetter BF, Clarke-Pearson DL, Kaufmann L, Parker RT. Management of stage IA carcinoma of the cervix. Am J Obstet Gynecol 1985;153:164-72.
6. Zreik TG, Chambers JT, Chambers SK. Parametrial involvement, regardless of nodal status: a poor prognostic factor for cervical cancer. Obstet Gynecol 1996;87:741-6.
7. Werner-Wasik M, Schmid CH, Bornstein L, Ball HG, Smith DM, Madoc-Jones H. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma. Int J Radiat Oncol Biol Phys 1995;32:1309-17.
8. Kamura T, Shigematsu T, Kaku T et al. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy. Acta Obstet Gynecol Scand 1999;78:452-7.
9. Aoki Y, Sasaki M, Watanabe M et al. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol 2000;77:305-9.
10. Takeda N, Sakuragi N, Takeda M et al. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand 2002;81:1144-51.
11. Stehman S, Ferez C, Kuman R, Thigpen J. Uterine cervix. In: Hoskins WJ, Ferez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology, 3rd edn. Lippincott: Williams & Wilkins, 2000.
12. Shingleton HM, Bell MC, Fremgen A et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer 1995;76:1948-55.
13. Trattner M, Graf AH, Lax S et al. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol Oncol 2001;82:11-6.
14. Shigematsu N, Ito H, Nishiguchi I et al. Prognostic factors of cervical carcinoma treated with postoperative radiotherapy. Nippon Igaku Hoshasen Gakkai Zasshi 1997;57:28-33.
15. Graflund M, Sorbe B, Hussein A, Bryne M, Karlsson M. The prognostic value of histopathologic grading parameters and microvessel density in patients with early squamous cell carcinoma of the uterine cervix. Int J Gynecol Cancer 2002;12:32-41.
16. Wilailak S, Tangtrakul S, Srisupundit S, Bullangpoti S, Linasmita V, Bhamarapravati Y. Prognostic factors associated with recurrence in stage IB cervical carcinoma after radical hysterectomy and pelvic lymphadenectomy. J Med Assoc Thai 1993;76:74-7.
17. Gerdin E, Cnattingius S, Johnson P, Pettersson B. Prognostic factors and relapse patterns in early-stage cervical carcinoma after brachytherapy and radical hysterectomy. Gynecol Oncol 1994;53:314-9.
18. Kainz C, Gitsch G, Tempfer C et al. Vascular space invasion and inflammatory stromal reaction as prognostic factors in patients with surgically treated cervical cancer stage IB to IIB. Anticancer Res 1994;14:2245-8.
19. Kosary CL. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 1994;10:31-46.
20. Sevin BU, Lu Y, Bloch DA, Nadji M, Koechli OR, Averette HE. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis. Cancer 1996;78:1438-46.
21. Chen RJ, Chang DY, Yen ML et al. Prognostic factors of primary adenocarcinoma of the uterine cervix. Gynecol Oncol 1998;69:157-64.
22. Yuan CC, Wang PH, Lai CR, Yen MS, Chen CY, Juang CM. Prognosis-predicting system based on factors related to survival of cervical carcinoma. Int J Gynaecol Obstet 1998;63:163-7.
23. Garipagaoglu M, Tulunay G, Kose MF, Yalvac S, Kayikcioglu F, Cakmak A. Prognostic factors in stage IB-IIA cervical carcinomas treated with postoperative radiotherapy. Eur J Gynaecol Oncol 1999;20:131-5.
24. Ishikawa H, Nakanishi T, Inoue T, Kuzuya K. Prognostic factors of adenocarcinoma of the uterine cervix. Gynecol Oncol 1999;73:42-6.
25. Atasii T, Aksu MF, Cetinkaya MB. Prognostic factors that affect survival after the treatment of early stage cervical carcinoma. Int Surg 2000;85:147-51.
26. Hong JH, Tsai CS, Wang CC et al. Comparison of clinical behaviors and responses to radiation between squamous cell carcinomas and adenocarcinomas/ adenosquamous carcinomas of the cervix. Changgeng Yi Xue Za Zhi 2000;23:396-404.
27. Alfsen GC, Kristensen GB, Skovlund E, Pettersen EO, Abeler VM. Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix. Cancer 2001;92:2471-83.
28. Birner P, Schindl M, Obermair A, Breitenecker G, Kowalski H, Oberhuber G. Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer 2001;95:29-33.
29. Grisaru DA, Covens A, Franssen E et al. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma. Cancer 2003;97:1904-8.
30. Tay SK, Tan LK. Outcome of early cervical carcinoma treated by wertheim hysterectomy with selective post-operative radiotherapy. Ann Acad Med Singapore 1998;27:613-7.
31. Kristensen GB, Abeler VM, Risberg B, Trop C, Bryne M. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma. Gynecol Oncol 1999;74:245-51.
32. Michel G, Morice P, Castaigne D, Leblanc M, Key A, Duvillard P. Lymphatic spread in stage Ib and II cervical carcinoma: anatomy and surgical implications. Obstet Gynecol 1998;91:360-3.
33. Sevin BU, Nadji M, Lampe B et al. Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer 1995;76:1978-86.
34. Nakanishi T, Ishikawa H, Suzuki Y, Inoue T, Nakamura S, Kuzuya K. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol 2000;79:289-93.
35. Tsai CS, Lai CH, Wang CC et al. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol Oncol 1999;75:328-33.
36. Tan R, Chung CH, Liu MT, Lai YL, Chang KH. Results of postoperative radiotherapy for clinical stage Ib uterine cervical carcinoma with evidence of microscopic involvement of surgical margin, parametrium and/or lymph node metastasis. J Formos Med Assoc 1991;90:836-9.
37. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 1990;38:352-7.
38. Morice P, Castaigne D, Pautier P et al. Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 1999;73:106-10.
39. Medl M, Peters-Engl C, Schutz P, Vesely M, Sevelda P. First report of lymphatic mapping with isosulfan blue dye and sentinel node biopsy in cervical cancer. Anticancer Res 2000;20:1133-4.
40. Lantzsch T, Wolters M, Grimm J et al. Sentinel node procedure in Ib cervical cancer: a preliminary series. Br J Cancer 2001;85:791-4.
41. Levenback C, Coleman RL, Burke TW et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 2002;20:688-93.
42. Rhim CC, Park JS, Bae SN, Namkoong SE. Sentinel node biopsy as an indicator for pelvic nodes dissection in early stage cervical cancer. J Korean Med Sci 2002;17:507-11.
43. van Dam PA, Hauspy J, Vanderheyden T et al. Intraoperative sentinel node identification with technetium-99m-labeled nanocolloid in patients with cancer of the uterine cervix: a feasibility study. Int J Gynecol Cancer 2003;13:182-6.
44. Buist MR, Pijpers RJ, van Lingen A et al. Laparoscopic detection of sentinel lymph nodes followed by lymph node dissection in patients with early stage cervical cancer. Gynecol Oncol 2003;90:290-6.
45. Plante M, Renaud MC, Tetu B, Harel F, Roy M. Laparoscopic sentinel node mapping in early-stage cervical cancer. Gynecol Oncol 2003;91:494-503.
46. Lambaudie E, Collinet P, Narducci F et al. Laparoscopic identification of sentinel lymph nodes in early stage cervical cancer: prospective study using a combination of patent blue dye injection and technetium radiocolloid injection. Gynecol Oncol 2003;89:84-7.
47. Czegledy J, Iosif C, Hansson BG, Evander M, Gergely L, Wadell G. Can a test for E6/E7 transcripts of human papillomavirus type 16 serve as a diagnostic tool for the detection of micrometastasis in cervical cancer? Int J Cancer 1995;64:211-5.
48. Ikenberg H, Wiegering II, Pfisterer J et al. Human papillomavirus DNA in tumor-free regional lymph nodes: A Potential Prognostic Marker in Cervical Carcinoma. Cancer J Sci Am 1996;2:28.
49. Van Trappen PO, Gyselman VG, Lowe DG et al. Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet 2001;357:15-20.
50. Greer BE, Figge DC, Tamimi HK, Cain JM, Lee RB. Stage IA2 squamous carcinoma of the cervix: difficult diagnosis and therapeutic dilemma. Am J Obstet Gynecol 1990;162:1406-9.
51. Burke TW, Hoskins WJ, Heller PB, Shen MC, Weiser EB, Park RC. Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma. Obstet Gynecol 1987;69:382-5.
52. Samlal RA, van der Velden J, Ten Kate FJ, Schilthuis MS, Hart AA, Lammes FB. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes. Cancer 1997;80:1234-40.
53. Lai CH, Hsueh S, Hong JH et al. Are adenocarcinomas and adenosquamous carcinomas different from squamous carcinomas in stage IB and II cervical cancer patients undergoing primary radical surgery? Int J Gynecol Cancer 1999;9:28-36.
54. Irie T, Kigawa J, Minagawa Y et al. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy. Eur J Surg Oncol 2000;26:464-7.
55. Huang HJ, Chang TC, Hong JH et al. Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (>/=4 cm) stage IB and IIA cervical carcinoma. Int J Gynecol Cancer 2003;13:204-11.
56. Quinn MA. Adenocarcinoma of the cervix-are there arguments for a different treatment policy? Curr Opin Obstet Gynecol 1997;9:21-4.
57. Chen RJ, Lin YH, Chen CA, Huang SC, Chow SN, Hsieh CY. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Gynecol Oncol 1999;73:184-90.
58. Eifel PJ, Burke TW, Morris M, Smith TL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol 1995;59:38-44.
59. Sakuragi N, Takeda N, Hareyama H et al. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma. Cancer 2000;88:2578-83.
60. Greer BE, Figge DC, Tamimi HK, Cain JM. Stage IB adenocarcinoma of the cervix treated by radical hysterectomy and pelvic lymph node dissection. Am J Obstet Gynecol 1989;160:1509-13.
61. Look KY, Brunetto VL, Clarke-Pearson DL et al. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: A Gynecologic Oncology Group Study. Gynecol Oncol 1996;63:304-11.
62. Waldenstrom AC, Horvath G. Survival of patients with adenocarcinoma of the uterine cervix in western Sweden. Int J Gynecol Cancer 1999;9:18-23.
63. Grisaru D, Covens A, Chapman B et al. Does histology influence prognosis in patients with early-stage cervical carcinoma? Cancer 2001;92:2999-3004.
64. Parley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Cancer 2003;97:2196-202.
65. Sigurdsson K, Hrafnkelsson J, Geirsson G, Gudmundsson J, Salvarsdottir A. Screening as a prognostic factor in cervical cancer: analysis of survival and prognostic factors based on Icelandic population data, 1964-1988. Gynecol Oncol 1991;43:64-70.
66. Zhou C, Gilks CB, Hayes M, Clement PB. Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases. Am J Surg Pathol 1998;22:113-20.
67. Kaku T, Enjoji M. Extremely well-differentiated adenocarcinoma ("adenoma malignum") of the cervix. Int J Gynecol Pathol 1983;2:28-41.
68. Gilks CB, Young RH, Aguirre P, DeLellis RA, Scully RE. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol 1989;13:717-29.
69. Young RH, Scully RE. Villoglandular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases. Cancer 1989;63:1773-9.
70. Jones MW, Silverberg SG, Kurman RJ. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: a clinicopathological study of 24 cases. Int J Gynecol Pathol 1993;12:1-7.
71. Khunamornpong S, Maleemonkol S, Siriaunkgul S, Pantusart A. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: a report of 15 cases including two with lymph node metastasis. J Med Assoc Thai 2001;84:882-8.
72. Utsugi K, Shimizu Y, Akiyama F, Hasumi K. Villoglandular papillary adenocarcinoma of the uterine cervix with bulky lymph node metastases. Eur J Obstet Gynecol Reprod Biol 2002;105:186-8.
73. Bouman A, Oosterhuis GJ, Naudin TC, van Doorn GA. Villoglandular papillary adenocarcinoma of the cervix. Beware of a wolf in sheep's clothing. Eur J Obstet Gynecol Reprod Biol 1999;87:183-9.
74. Collinet P, Prolongeau JF, Vaneecloo S. Villoglandular papillary adenocarcinoma of the uterine cervix. Eur J Obstet Gynecol Reprod Biol 1999;86:101-3.
75. Morrison C, Catania F, Wakely P Jr, Nuovo GJ. Highly differentiated keratinizing squamous cell cancer of the cervix: a rare, locally aggressive tumor not associated with human papillomavirus or squamous intraepithelial lesions. Am J Surg Pathol 2001;25:1310-5.
76. Conner MG, Richter H, Moran CA, Hameed A, Albores-Saavedra J. Small cell carcinoma of the cervix: a clinicopathologic and immunohistochemical study of 23 cases. Ann Diagn Pathol 2002;6:345-8.
77. Weed JC Jr, Graff AT, Shoup B, Tawfik O. Small cell undifferentiated (neuroendocrine) carcinoma of the uterine cervix. J Am Coll Surg 2003;197:44-51.
78. van Dinh T, Woodruff JD. Adenoid cystic and adenoid basal carcinomas of the cervix. Obstet Gynecol 1985;65:705-9.
79. Ferry JA, Scully RE. "Adenoid cystic" carcinoma and adenoid basal carcinoma of the uterine cervix. A study of 28 cases. Am J Surg Pathol 1988;12:134-44.
80. Stendahl U, Willen H, Willen R. Invasive squamous cell carcinoma of the uterine cervix. I. Definition of parameters in a histopathologic malignancy grading system. Acta Radiol Oncol 1980;19:467-80.
81. Chung CK, Stryker JA, Ward SP, Nahhas WA, Mortel R. Histologic grade and prognosis of carcinoma of the cervix. Obstet Gynecol 1981;57:636-42.
82. Zaino RJ, Ward S, Delgado G et al. Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. Cancer 1992;69:1750-8.
83. Stendahl U, Willen H, Willen R. Classification and grading of invasive squamous cell carcinoma of the uterine cervix. Acta Radiol Oncol Radiat Phys Biol 1979;18:481-96.
84. Burghardt E, Holzer E. Diagnosis and treatment of microinvasive carcinoma of the cervix uteri. Obstet Gynecol 1977;49:641-53.
85. Pickel H, Haas J, Lahousen M. Prognostic factors in cervical cancer. Eur J Obstet Gynecol Reprod Biol 1997;71:209-13.
86. deSouza NM, McIndoe GA, Soutter WP et al. Value of magnetic resonance imaging with an endovaginal receiver coil in the pre-operative assessment of Stage I and IIa cervical neoplasia. Br J Obstet Gynaecol 1998;105:500-7.
87. Oellinger JJ, Blohmer JU, Michniewicz K et al. Pre-operative staging of cervical cancer: comparison of magnetic resonance imaging (MRI) and computed tomography (CT) with histologic results. Zentralbl Gynakol 2000;122:82-91.
88. Chiang SH, Quek ST. Carcinoma of the cervix: role of MR Imaging. Ann Acad Med Singapore 2003;32:550-6.
89. Martin-Loeches M, Orti RM, Cazorla E, Asins E, Llixiona J. Multivariate analysis of the morphometric characteristics of tumours as prognostic factors in the survival of patients with uterine cervix cancer treated with radical surgery. Eur J Obstet Gynecol Reprod Biol 2002;105:170-6.
90. Aoki Y, Watanabe M, Sasaki M et al. Prognostic factors and failure pattern in lymph node-negative stage IB and II cervical carcinoma treated with radical hysterectomy and post-operative irradiation. Gynecol Obstet Invest 2001;52:13-7.
91. Roman LD, Felix JC, Muderspach LI et al. Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix. Gynecol Oncol 1998;68:220-5.
92. Morice P, Piovesan P, Rey A et al. Prognostic value of lymphovascular space invasion determined withs hematoxylin-eosin staining in early stage cervical carcinoma: results of a multivariate analysis. Ann Oncol 2003;14:1511-7.
93. Sykes P, Allen D, Cohen C, Scurry J, Yeo D. Does the density of lymphatic vascular space invasion affect the prognosis of stage Ib and IIA node negative carcinoma of the cervix? Int J Gynecol Cancer 2003;13:313-6.
94. Comerci G, Bolger BS, Flannelly G, Maini M, de Barros LA, Monaghan JM. Prognostic factors in surgically treated stage IB-IIB carcinoma of the cervix with negative lymph nodes. Int J Gynecol Cancer 1998;8:23-6.
95. Memarzadeh S, Natarajan S, Dandade DP et al. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer. Obstet Gynecol 2003;102:612-9.